vs
COMMUNITY HEALTH SYSTEMS INC（CYH）与雅诗兰黛（EL）财务数据对比。点击上方公司名可切换其他公司
雅诗兰黛的季度营收约是COMMUNITY HEALTH SYSTEMS INC的1.4倍（$4.2B vs $3.1B），雅诗兰黛净利率更高（3.8% vs 3.5%，领先0.3%），雅诗兰黛同比增速更快（5.6% vs -4.8%），雅诗兰黛自由现金流更多（$1.0B vs $172.0M），过去两年雅诗兰黛的营收复合增速更高（3.6% vs -0.5%）
社区卫生系统公司总部位于美国田纳西州富兰克林，是财富500强企业。按急症护理机构数量计算，该公司曾是美国最大的综合医院医疗服务提供商。2014年它旗下有约200家医院，到2021年机构数量缩减至约85家。
雅诗兰黛是全球知名的高端美妆集团，由创始人雅诗·兰黛女士与丈夫约瑟夫·劳特共同创立。雅诗·兰黛女士也是唯一一位登上《时代》杂志1998年“20世纪20位最具影响力商业天才”榜单的女性，集团旗下拥有多个知名美妆、护肤、香氛品牌，业务覆盖全球众多国家和地区。
CYH vs EL — 直观对比
营收规模更大
EL
是对方的1.4倍
$3.1B
营收增速更快
EL
高出10.5%
-4.8%
净利率更高
EL
高出0.3%
3.5%
自由现金流更多
EL
多$845.0M
$172.0M
两年增速更快
EL
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.1B | $4.2B |
| 净利润 | $110.0M | $162.0M |
| 毛利率 | 85.6% | 76.5% |
| 营业利润率 | 14.5% | 9.5% |
| 净利率 | 3.5% | 3.8% |
| 营收同比 | -4.8% | 5.6% |
| 净利润同比 | 254.9% | 127.5% |
| 每股收益（稀释后） | $0.82 | $0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CYHEL
| Q4 25 | $3.1B | $4.2B | ||
| Q3 25 | $3.1B | $3.5B | ||
| Q2 25 | $3.1B | $3.4B | ||
| Q1 25 | $3.2B | $3.5B | ||
| Q4 24 | $3.3B | $4.0B | ||
| Q3 24 | $3.1B | $3.4B | ||
| Q2 24 | $3.1B | $3.9B | ||
| Q1 24 | $3.1B | $3.9B |
净利润CYHEL
| Q4 25 | $110.0M | $162.0M | ||
| Q3 25 | $130.0M | $47.0M | ||
| Q2 25 | $282.0M | $-546.0M | ||
| Q1 25 | $-13.0M | $159.0M | ||
| Q4 24 | $-71.0M | $-590.0M | ||
| Q3 24 | $-391.0M | $-156.0M | ||
| Q2 24 | $-13.0M | $-286.0M | ||
| Q1 24 | $-41.0M | $335.0M |
毛利率CYHEL
| Q4 25 | 85.6% | 76.5% | ||
| Q3 25 | 85.1% | 73.4% | ||
| Q2 25 | 85.0% | 72.0% | ||
| Q1 25 | 84.5% | 75.0% | ||
| Q4 24 | 84.5% | 76.1% | ||
| Q3 24 | 84.8% | 72.4% | ||
| Q2 24 | 84.6% | 71.8% | ||
| Q1 24 | 84.5% | 71.9% |
营业利润率CYHEL
| Q4 25 | 14.5% | 9.5% | ||
| Q3 25 | 7.9% | 4.9% | ||
| Q2 25 | 16.3% | -11.4% | ||
| Q1 25 | 9.0% | 8.6% | ||
| Q4 24 | 8.5% | -14.5% | ||
| Q3 24 | -6.6% | -3.6% | ||
| Q2 24 | 7.6% | -6.0% | ||
| Q1 24 | 7.4% | 13.5% |
净利率CYHEL
| Q4 25 | 3.5% | 3.8% | ||
| Q3 25 | 4.2% | 1.4% | ||
| Q2 25 | 9.0% | -16.0% | ||
| Q1 25 | -0.4% | 4.5% | ||
| Q4 24 | -2.2% | -14.7% | ||
| Q3 24 | -12.7% | -4.6% | ||
| Q2 24 | -0.4% | -7.4% | ||
| Q1 24 | -1.3% | 8.5% |
每股收益（稀释后）CYHEL
| Q4 25 | $0.82 | $0.44 | ||
| Q3 25 | $0.96 | $0.13 | ||
| Q2 25 | $2.09 | $-1.52 | ||
| Q1 25 | $-0.10 | $0.44 | ||
| Q4 24 | $-0.53 | $-1.64 | ||
| Q3 24 | $-2.95 | $-0.43 | ||
| Q2 24 | $-0.10 | $-0.79 | ||
| Q1 24 | $-0.32 | $0.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $260.0M | — |
| 总债务越低越好 | $10.4B | $7.3B |
| 股东权益账面价值 | $-1.4B | $4.0B |
| 总资产 | $13.2B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 1.82× |
8季度趋势，按日历期对齐
现金及短期投资CYHEL
| Q4 25 | $260.0M | — | ||
| Q3 25 | $123.0M | — | ||
| Q2 25 | $456.0M | — | ||
| Q1 25 | $431.0M | — | ||
| Q4 24 | $37.0M | — | ||
| Q3 24 | $33.0M | — | ||
| Q2 24 | $39.0M | — | ||
| Q1 24 | $48.0M | — |
总债务CYHEL
| Q4 25 | $10.4B | $7.3B | ||
| Q3 25 | — | $7.3B | ||
| Q2 25 | — | $7.3B | ||
| Q1 25 | — | $7.3B | ||
| Q4 24 | $11.5B | $7.3B | ||
| Q3 24 | — | $7.3B | ||
| Q2 24 | — | $7.3B | ||
| Q1 24 | — | $7.3B |
股东权益CYHEL
| Q4 25 | $-1.4B | $4.0B | ||
| Q3 25 | $-1.5B | $3.9B | ||
| Q2 25 | $-1.6B | $3.9B | ||
| Q1 25 | $-1.9B | $4.3B | ||
| Q4 24 | $-1.9B | $4.2B | ||
| Q3 24 | $-1.8B | $5.1B | ||
| Q2 24 | $-1.4B | $5.3B | ||
| Q1 24 | $-1.4B | $5.7B |
总资产CYHEL
| Q4 25 | $13.2B | $19.6B | ||
| Q3 25 | $13.2B | $19.3B | ||
| Q2 25 | $13.6B | $19.9B | ||
| Q1 25 | $13.9B | $19.9B | ||
| Q4 24 | $14.1B | $19.8B | ||
| Q3 24 | $13.9B | $21.3B | ||
| Q2 24 | $14.4B | $21.7B | ||
| Q1 24 | $14.4B | $22.7B |
负债/权益比CYHEL
| Q4 25 | — | 1.82× | ||
| Q3 25 | — | 1.88× | ||
| Q2 25 | — | 1.89× | ||
| Q1 25 | — | 1.68× | ||
| Q4 24 | — | 1.75× | ||
| Q3 24 | — | 1.44× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 1.26× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $266.0M | $1.1B |
| 自由现金流经营现金流 - 资本支出 | $172.0M | $1.0B |
| 自由现金流率自由现金流/营收 | 5.5% | 24.0% |
| 资本支出强度资本支出/营收 | 3.0% | 2.6% |
| 现金转化率经营现金流/净利润 | 2.42× | 6.94× |
| 过去12个月自由现金流最近4个季度 | $208.0M | $1.1B |
8季度趋势，按日历期对齐
经营现金流CYHEL
| Q4 25 | $266.0M | $1.1B | ||
| Q3 25 | $69.0M | $-340.0M | ||
| Q2 25 | $88.0M | $601.0M | ||
| Q1 25 | $120.0M | $284.0M | ||
| Q4 24 | $216.0M | $1.1B | ||
| Q3 24 | $67.0M | $-670.0M | ||
| Q2 24 | $101.0M | $889.0M | ||
| Q1 24 | $96.0M | $534.0M |
自由现金流CYHEL
| Q4 25 | $172.0M | $1.0B | ||
| Q3 25 | $4.0M | $-436.0M | ||
| Q2 25 | $-3.0M | $394.0M | ||
| Q1 25 | $35.0M | $162.0M | ||
| Q4 24 | $107.0M | $925.0M | ||
| Q3 24 | $-3.0M | $-811.0M | ||
| Q2 24 | $13.0M | $672.0M | ||
| Q1 24 | $3.0M | $359.0M |
自由现金流率CYHEL
| Q4 25 | 5.5% | 24.0% | ||
| Q3 25 | 0.1% | -12.5% | ||
| Q2 25 | -0.1% | 11.6% | ||
| Q1 25 | 1.1% | 4.6% | ||
| Q4 24 | 3.3% | 23.1% | ||
| Q3 24 | -0.1% | -24.1% | ||
| Q2 24 | 0.4% | 17.4% | ||
| Q1 24 | 0.1% | 9.1% |
资本支出强度CYHEL
| Q4 25 | 3.0% | 2.6% | ||
| Q3 25 | 2.1% | 2.8% | ||
| Q2 25 | 2.9% | 6.1% | ||
| Q1 25 | 2.7% | 3.4% | ||
| Q4 24 | 3.3% | 3.3% | ||
| Q3 24 | 2.3% | 4.2% | ||
| Q2 24 | 2.8% | 5.6% | ||
| Q1 24 | 3.0% | 4.4% |
现金转化率CYHEL
| Q4 25 | 2.42× | 6.94× | ||
| Q3 25 | 0.53× | -7.23× | ||
| Q2 25 | 0.31× | — | ||
| Q1 25 | — | 1.79× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.59× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CYH
| Managed Care And Other Third Party Payors | $1.5B | 49% |
| Medicare Managed Care | $570.0M | 18% |
| Medicare | $512.0M | 16% |
| Medicaid | $464.0M | 15% |
| Self Pay Revenue | $34.0M | 1% |
EL
| Skin Care | $2.1B | 49% |
| Makeup | $1.2B | 28% |
| Fragrance | $812.0M | 19% |
| Hair Care | $168.0M | 4% |
| Other | $31.0M | 1% |
